Mamuka Kvaratskhelia
Concepts (415)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Integrase | 38 | 2024 | 73 | 10.120 |
Why?
| | HIV-1 | 47 | 2025 | 895 | 9.550 |
Why?
| | HIV Integrase Inhibitors | 25 | 2024 | 72 | 7.750 |
Why?
| | Virus Integration | 18 | 2025 | 69 | 3.780 |
Why?
| | Drug Resistance, Viral | 6 | 2025 | 120 | 2.680 |
Why?
| | Virus Replication | 14 | 2025 | 532 | 2.630 |
Why?
| | Anti-HIV Agents | 7 | 2025 | 860 | 2.460 |
Why?
| | Protein Multimerization | 9 | 2020 | 194 | 2.450 |
Why?
| | Intercellular Signaling Peptides and Proteins | 11 | 2021 | 389 | 2.360 |
Why?
| | Capsid | 8 | 2025 | 91 | 1.810 |
Why?
| | Capsid Proteins | 7 | 2025 | 95 | 1.740 |
Why?
| | DNA, Viral | 11 | 2022 | 367 | 1.600 |
Why?
| | Protein Binding | 44 | 2025 | 2242 | 1.580 |
Why?
| | RNA, Viral | 14 | 2022 | 693 | 1.530 |
Why?
| | Virion | 7 | 2022 | 113 | 1.460 |
Why?
| | HIV Infections | 19 | 2025 | 3022 | 1.400 |
Why?
| | HEK293 Cells | 23 | 2025 | 737 | 1.270 |
Why?
| | Integrases | 6 | 2017 | 123 | 1.120 |
Why?
| | Virus Assembly | 6 | 2025 | 79 | 1.120 |
Why?
| | Acetamides | 2 | 2025 | 36 | 1.110 |
Why?
| | Indazoles | 2 | 2025 | 74 | 1.090 |
Why?
| | Leukemia Virus, Murine | 4 | 2016 | 19 | 1.060 |
Why?
| | Allosteric Regulation | 13 | 2023 | 89 | 1.000 |
Why?
| | Gene Products, gag | 4 | 2018 | 38 | 0.990 |
Why?
| | Retroviridae | 3 | 2025 | 103 | 0.970 |
Why?
| | Models, Molecular | 24 | 2025 | 1604 | 0.950 |
Why?
| | Mass Spectrometry | 15 | 2017 | 740 | 0.950 |
Why?
| | Antiviral Agents | 6 | 2024 | 747 | 0.920 |
Why?
| | Endodeoxyribonucleases | 8 | 2001 | 73 | 0.900 |
Why?
| | Human T-lymphotropic virus 1 | 7 | 2023 | 32 | 0.890 |
Why?
| | Acetates | 3 | 2014 | 82 | 0.880 |
Why?
| | Nucleosomes | 3 | 2022 | 155 | 0.870 |
Why?
| | Pyrazines | 1 | 2025 | 88 | 0.860 |
Why?
| | Pyridines | 2 | 2019 | 557 | 0.860 |
Why?
| | HIV Reverse Transcriptase | 7 | 2019 | 31 | 0.840 |
Why?
| | Nuclear Pore Complex Proteins | 5 | 2025 | 37 | 0.830 |
Why?
| | Mutation, Missense | 3 | 2014 | 340 | 0.820 |
Why?
| | Prions | 1 | 2022 | 51 | 0.750 |
Why?
| | Genome, Viral | 4 | 2021 | 223 | 0.740 |
Why?
| | Nuclear Proteins | 5 | 2016 | 719 | 0.740 |
Why?
| | Transcription Factors | 7 | 2017 | 1712 | 0.730 |
Why?
| | HIV Seropositivity | 1 | 2022 | 127 | 0.720 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 8 | 2014 | 145 | 0.720 |
Why?
| | Crystallography, X-Ray | 7 | 2025 | 485 | 0.670 |
Why?
| | Protein Conformation | 14 | 2025 | 941 | 0.660 |
Why?
| | Vesicular Transport Proteins | 1 | 2021 | 85 | 0.650 |
Why?
| | Protein Structure, Tertiary | 14 | 2016 | 859 | 0.560 |
Why?
| | Gene Products, pol | 1 | 2017 | 6 | 0.550 |
Why?
| | Sulfolobus | 7 | 2001 | 11 | 0.550 |
Why?
| | Quinolines | 3 | 2014 | 172 | 0.530 |
Why?
| | DNA | 13 | 2014 | 1444 | 0.520 |
Why?
| | Humans | 66 | 2025 | 141754 | 0.510 |
Why?
| | Protein Interaction Domains and Motifs | 6 | 2019 | 150 | 0.500 |
Why?
| | Archaeal Proteins | 3 | 2001 | 45 | 0.500 |
Why?
| | Binding Sites | 15 | 2021 | 1316 | 0.490 |
Why?
| | Amino Acid Sequence | 19 | 2019 | 2158 | 0.480 |
Why?
| | Recombinant Proteins | 6 | 2013 | 1363 | 0.470 |
Why?
| | Recombination, Genetic | 6 | 2001 | 206 | 0.460 |
Why?
| | Molecular Sequence Data | 19 | 2015 | 2929 | 0.450 |
Why?
| | Protein Footprinting | 6 | 2011 | 11 | 0.440 |
Why?
| | Moloney murine leukemia virus | 1 | 2014 | 13 | 0.440 |
Why?
| | HeLa Cells | 5 | 2020 | 640 | 0.430 |
Why?
| | Transcription Initiation Site | 2 | 2014 | 43 | 0.430 |
Why?
| | Myxovirus Resistance Proteins | 3 | 2025 | 13 | 0.430 |
Why?
| | Viral Proteins | 5 | 2016 | 369 | 0.400 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2015 | 235 | 0.400 |
Why?
| | Nucleic Acid Conformation | 9 | 2021 | 725 | 0.400 |
Why?
| | Cell Line | 12 | 2025 | 2887 | 0.400 |
Why?
| | Cell Cycle Proteins | 6 | 2017 | 632 | 0.390 |
Why?
| | Protein Domains | 5 | 2025 | 304 | 0.390 |
Why?
| | beta Karyopherins | 1 | 2012 | 8 | 0.380 |
Why?
| | Host-Pathogen Interactions | 5 | 2021 | 372 | 0.380 |
Why?
| | Integrase Inhibitors | 1 | 2012 | 1 | 0.380 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 2 | 2022 | 27 | 0.360 |
Why?
| | Avian Leukosis Virus | 2 | 2017 | 6 | 0.350 |
Why?
| | RNA, Transfer | 2 | 2016 | 139 | 0.340 |
Why?
| | Mutation | 8 | 2025 | 4015 | 0.330 |
Why?
| | Indoles | 1 | 2014 | 478 | 0.330 |
Why?
| | Archaea | 2 | 2001 | 84 | 0.330 |
Why?
| | Catalytic Domain | 8 | 2016 | 224 | 0.330 |
Why?
| | Nuclear Pore | 2 | 2021 | 16 | 0.320 |
Why?
| | Proteins | 4 | 2020 | 1015 | 0.310 |
Why?
| | Viral Nonstructural Proteins | 3 | 2016 | 67 | 0.310 |
Why?
| | Gene Products, tax | 3 | 2019 | 15 | 0.300 |
Why?
| | Peptides | 5 | 2018 | 979 | 0.300 |
Why?
| | DNA Footprinting | 1 | 2008 | 33 | 0.300 |
Why?
| | Structure-Activity Relationship | 5 | 2021 | 579 | 0.280 |
Why?
| | DNA-Binding Proteins | 9 | 2017 | 1485 | 0.280 |
Why?
| | Hepacivirus | 3 | 2016 | 238 | 0.280 |
Why?
| | RNA-Binding Proteins | 4 | 2018 | 447 | 0.270 |
Why?
| | Histones | 3 | 2022 | 639 | 0.270 |
Why?
| | Salicylates | 2 | 2016 | 29 | 0.260 |
Why?
| | Cytoplasm | 2 | 2021 | 273 | 0.260 |
Why?
| | Molecular Dynamics Simulation | 2 | 2020 | 246 | 0.250 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 6 | 2008 | 336 | 0.250 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 225 | 0.240 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2006 | 32 | 0.240 |
Why?
| | Holliday Junction Resolvases | 8 | 2001 | 8 | 0.240 |
Why?
| | Active Transport, Cell Nucleus | 3 | 2025 | 122 | 0.240 |
Why?
| | Lysine | 8 | 2022 | 292 | 0.240 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2017 | 43 | 0.240 |
Why?
| | Ribonuclease H, Human Immunodeficiency Virus | 2 | 2019 | 2 | 0.230 |
Why?
| | DNA Damage | 4 | 2021 | 429 | 0.230 |
Why?
| | Pyridoxal Phosphate | 1 | 2004 | 24 | 0.220 |
Why?
| | Avian Sarcoma Viruses | 1 | 2004 | 4 | 0.220 |
Why?
| | Cyclophilins | 1 | 2025 | 40 | 0.220 |
Why?
| | Aptamers, Nucleotide | 2 | 2018 | 85 | 0.220 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 3 | 2021 | 70 | 0.210 |
Why?
| | Biotin | 2 | 2005 | 26 | 0.210 |
Why?
| | Protein Processing, Post-Translational | 3 | 2017 | 464 | 0.210 |
Why?
| | Y-Box-Binding Protein 1 | 1 | 2023 | 6 | 0.210 |
Why?
| | Viral Envelope Proteins | 1 | 2004 | 97 | 0.210 |
Why?
| | Magnesium | 3 | 2000 | 158 | 0.200 |
Why?
| | Receptors, Virus | 2 | 2019 | 96 | 0.200 |
Why?
| | Chromatography, Gel | 4 | 2009 | 131 | 0.200 |
Why?
| | RNA, Transfer, Lys | 1 | 2002 | 3 | 0.200 |
Why?
| | Succinimides | 1 | 2002 | 19 | 0.200 |
Why?
| | Molecular Chaperones | 1 | 2025 | 198 | 0.200 |
Why?
| | Cell Nucleus | 2 | 2021 | 609 | 0.200 |
Why?
| | Protein Structure, Quaternary | 4 | 2008 | 120 | 0.200 |
Why?
| | Mutagenesis, Site-Directed | 6 | 2009 | 377 | 0.190 |
Why?
| | Xeroderma Pigmentosum Group A Protein | 2 | 2014 | 5 | 0.190 |
Why?
| | Molecular Docking Simulation | 3 | 2019 | 111 | 0.190 |
Why?
| | Chromosomes, Human | 1 | 2022 | 44 | 0.190 |
Why?
| | Drugs, Investigational | 1 | 2022 | 32 | 0.190 |
Why?
| | Histone Code | 1 | 2022 | 33 | 0.190 |
Why?
| | Phenylalanine | 1 | 2022 | 67 | 0.190 |
Why?
| | Carboxylic Acids | 2 | 2019 | 34 | 0.190 |
Why?
| | Thiophenes | 2 | 2016 | 127 | 0.190 |
Why?
| | Oligonucleotides | 3 | 2018 | 149 | 0.190 |
Why?
| | Protein Subunits | 2 | 2015 | 232 | 0.190 |
Why?
| | Cryoelectron Microscopy | 2 | 2020 | 193 | 0.180 |
Why?
| | Proteolysis | 3 | 2017 | 175 | 0.180 |
Why?
| | Viral Core Proteins | 2 | 2012 | 22 | 0.180 |
Why?
| | Drug Discovery | 3 | 2019 | 147 | 0.180 |
Why?
| | Cyclophilin A | 2 | 2024 | 26 | 0.180 |
Why?
| | Glycine | 1 | 2022 | 185 | 0.180 |
Why?
| | HTLV-I Infections | 4 | 2019 | 28 | 0.180 |
Why?
| | Peroxidases | 2 | 1999 | 35 | 0.170 |
Why?
| | Reverse Transcription | 1 | 2021 | 20 | 0.170 |
Why?
| | Lentiviruses, Primate | 1 | 2021 | 12 | 0.170 |
Why?
| | RNA | 1 | 2008 | 930 | 0.170 |
Why?
| | Isoenzymes | 3 | 1999 | 302 | 0.170 |
Why?
| | Chromatin | 2 | 2022 | 533 | 0.170 |
Why?
| | Deuterium Exchange Measurement | 1 | 2020 | 27 | 0.170 |
Why?
| | Purines | 1 | 2002 | 182 | 0.170 |
Why?
| | Tea | 2 | 1997 | 16 | 0.170 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 1 | 2021 | 54 | 0.170 |
Why?
| | Manganese | 2 | 1999 | 57 | 0.160 |
Why?
| | Enzyme Inhibitors | 1 | 2004 | 855 | 0.160 |
Why?
| | Cross-Linking Reagents | 2 | 2016 | 208 | 0.160 |
Why?
| | Base Sequence | 7 | 2016 | 2180 | 0.160 |
Why?
| | Necrosis | 1 | 2021 | 249 | 0.160 |
Why?
| | Retroviridae Proteins | 2 | 2017 | 10 | 0.160 |
Why?
| | Neuroblastoma | 1 | 2021 | 163 | 0.160 |
Why?
| | Reverse Transcriptase Inhibitors | 2 | 2011 | 87 | 0.160 |
Why?
| | Amino Acid Substitution | 2 | 2013 | 310 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2013 | 439 | 0.150 |
Why?
| | Stereoisomerism | 1 | 2019 | 107 | 0.150 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2000 | 403 | 0.150 |
Why?
| | Animals | 13 | 2025 | 37749 | 0.150 |
Why?
| | Protein Interaction Mapping | 3 | 2012 | 103 | 0.150 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 48 | 0.150 |
Why?
| | Amino Acids | 1 | 2022 | 497 | 0.150 |
Why?
| | Gene Products, vpr | 1 | 2018 | 2 | 0.150 |
Why?
| | Glycerol | 1 | 2018 | 91 | 0.140 |
Why?
| | Substrate Specificity | 4 | 2016 | 385 | 0.140 |
Why?
| | Protein Folding | 2 | 2016 | 278 | 0.140 |
Why?
| | Surface Plasmon Resonance | 1 | 2017 | 88 | 0.130 |
Why?
| | High Mobility Group Proteins | 1 | 2017 | 44 | 0.130 |
Why?
| | Immunoblotting | 2 | 2016 | 310 | 0.130 |
Why?
| | Peroxidase | 1 | 1997 | 182 | 0.130 |
Why?
| | Transcriptional Elongation Factors | 1 | 2017 | 38 | 0.130 |
Why?
| | 5' Untranslated Regions | 2 | 2021 | 59 | 0.130 |
Why?
| | meta-Aminobenzoates | 1 | 2016 | 1 | 0.130 |
Why?
| | alpha-Defensins | 1 | 2016 | 11 | 0.130 |
Why?
| | Nucleocapsid | 1 | 2016 | 18 | 0.130 |
Why?
| | Adenosine | 1 | 2018 | 253 | 0.130 |
Why?
| | Protein Structure, Secondary | 3 | 2008 | 368 | 0.120 |
Why?
| | Mutant Proteins | 2 | 2014 | 102 | 0.120 |
Why?
| | Ribonuclease P | 1 | 2016 | 22 | 0.120 |
Why?
| | DNA Packaging | 1 | 2016 | 24 | 0.120 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2016 | 188 | 0.120 |
Why?
| | DNA, Single-Stranded | 3 | 2006 | 120 | 0.120 |
Why?
| | Dynamic Light Scattering | 1 | 2016 | 7 | 0.120 |
Why?
| | Nucleic Acids | 1 | 2016 | 71 | 0.120 |
Why?
| | Calcium | 2 | 2021 | 1192 | 0.120 |
Why?
| | Morphogenesis | 1 | 2016 | 171 | 0.120 |
Why?
| | Drug Design | 1 | 2016 | 168 | 0.120 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 149 | 0.120 |
Why?
| | Spectrometry, Fluorescence | 1 | 2016 | 167 | 0.110 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2005 | 391 | 0.110 |
Why?
| | Models, Chemical | 1 | 2016 | 272 | 0.110 |
Why?
| | Biotinylation | 2 | 2006 | 32 | 0.110 |
Why?
| | DEAD-box RNA Helicases | 2 | 2016 | 86 | 0.110 |
Why?
| | Histidine | 1 | 2014 | 65 | 0.110 |
Why?
| | Microbial Sensitivity Tests | 1 | 2016 | 370 | 0.110 |
Why?
| | Gene Knockout Techniques | 1 | 2014 | 117 | 0.100 |
Why?
| | Hepatitis C | 1 | 2016 | 250 | 0.100 |
Why?
| | Circular Dichroism | 2 | 2012 | 148 | 0.100 |
Why?
| | Escherichia coli | 4 | 2007 | 838 | 0.100 |
Why?
| | Peptide Mapping | 2 | 2007 | 65 | 0.100 |
Why?
| | Nucleoproteins | 2 | 2017 | 37 | 0.100 |
Why?
| | Carrier Proteins | 1 | 2017 | 748 | 0.100 |
Why?
| | DNA Repair | 2 | 2009 | 239 | 0.100 |
Why?
| | Hydrolysis | 3 | 2007 | 196 | 0.100 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 136 | 0.100 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 444 | 0.100 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2014 | 547 | 0.100 |
Why?
| | Genetic Vectors | 1 | 2014 | 336 | 0.100 |
Why?
| | Azepines | 1 | 2013 | 97 | 0.100 |
Why?
| | Human T-lymphotropic virus 2 | 1 | 2012 | 1 | 0.100 |
Why?
| | HTLV-II Infections | 1 | 2012 | 3 | 0.100 |
Why?
| | Thermodynamics | 3 | 2020 | 424 | 0.100 |
Why?
| | Gene Expression Regulation, Viral | 3 | 2021 | 99 | 0.100 |
Why?
| | Scattering, Small Angle | 1 | 2012 | 26 | 0.100 |
Why?
| | Indoleacetic Acids | 1 | 2012 | 11 | 0.090 |
Why?
| | Calorimetry | 3 | 2001 | 71 | 0.090 |
Why?
| | X-Ray Diffraction | 1 | 2012 | 104 | 0.090 |
Why?
| | Genetic Therapy | 1 | 2014 | 315 | 0.090 |
Why?
| | Triazoles | 1 | 2013 | 162 | 0.090 |
Why?
| | Cell Line, Tumor | 2 | 2013 | 3495 | 0.090 |
Why?
| | Potassium Permanganate | 2 | 2002 | 3 | 0.090 |
Why?
| | RNA Interference | 1 | 2013 | 469 | 0.090 |
Why?
| | Leukemia-Lymphoma, Adult T-Cell | 1 | 2011 | 17 | 0.090 |
Why?
| | Virology | 1 | 2010 | 36 | 0.080 |
Why?
| | Nerve Tissue Proteins | 1 | 2014 | 605 | 0.080 |
Why?
| | Kinetics | 4 | 2009 | 1655 | 0.080 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2011 | 176 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 161 | 0.080 |
Why?
| | DNA Polymerase beta | 1 | 2009 | 5 | 0.080 |
Why?
| | Ribonuclease H | 3 | 2007 | 12 | 0.080 |
Why?
| | Cloning, Molecular | 2 | 2000 | 533 | 0.080 |
Why?
| | Furans | 1 | 2008 | 24 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 326 | 0.070 |
Why?
| | Urea | 1 | 2008 | 81 | 0.070 |
Why?
| | Conserved Sequence | 2 | 2017 | 238 | 0.070 |
Why?
| | Models, Biological | 3 | 2019 | 1828 | 0.070 |
Why?
| | Autoantigens | 1 | 2011 | 426 | 0.070 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 444 | 0.070 |
Why?
| | Nuclear Lamina | 1 | 2007 | 9 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2010 | 434 | 0.070 |
Why?
| | Macromolecular Substances | 2 | 2010 | 226 | 0.070 |
Why?
| | Multiprotein Complexes | 2 | 2011 | 172 | 0.060 |
Why?
| | RNA Splicing | 2 | 2015 | 270 | 0.060 |
Why?
| | Phytic Acid | 1 | 2006 | 42 | 0.060 |
Why?
| | RNA, Small Interfering | 2 | 2023 | 627 | 0.060 |
Why?
| | Proteomics | 1 | 2013 | 1138 | 0.060 |
Why?
| | Ultraviolet Rays | 1 | 2009 | 401 | 0.060 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2006 | 81 | 0.060 |
Why?
| | Ribonucleoproteins | 2 | 2020 | 105 | 0.060 |
Why?
| | Electron Spin Resonance Spectroscopy | 3 | 1999 | 97 | 0.060 |
Why?
| | Inhibitory Concentration 50 | 1 | 2004 | 91 | 0.060 |
Why?
| | Phosphorylation | 3 | 2021 | 1774 | 0.060 |
Why?
| | Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2004 | 9 | 0.060 |
Why?
| | Viral Fusion Proteins | 1 | 2004 | 19 | 0.060 |
Why?
| | Calreticulin | 1 | 2004 | 28 | 0.050 |
Why?
| | Avian Proteins | 1 | 2004 | 22 | 0.050 |
Why?
| | Carbohydrate Metabolism | 1 | 2004 | 62 | 0.050 |
Why?
| | Carbohydrates | 1 | 2004 | 68 | 0.050 |
Why?
| | Dimerization | 4 | 2007 | 196 | 0.050 |
Why?
| | Chickens | 1 | 2004 | 189 | 0.050 |
Why?
| | Glycosylation | 1 | 2004 | 163 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2010 | 1115 | 0.050 |
Why?
| | Terminal Repeat Sequences | 1 | 2023 | 18 | 0.050 |
Why?
| | GTP Phosphohydrolases | 1 | 2024 | 93 | 0.050 |
Why?
| | Genes, Viral | 1 | 2023 | 92 | 0.050 |
Why?
| | Oxidation-Reduction | 2 | 1997 | 1087 | 0.050 |
Why?
| | Oxazines | 1 | 2023 | 32 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 152 | 0.050 |
Why?
| | Acetylation | 1 | 2004 | 245 | 0.050 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 2003 | 34 | 0.050 |
Why?
| | Thymine | 1 | 2003 | 16 | 0.050 |
Why?
| | Retroelements | 1 | 2003 | 49 | 0.050 |
Why?
| | DNA, Fungal | 1 | 2003 | 80 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2002 | 110 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 987 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2022 | 81 | 0.050 |
Why?
| | Base Pair Mismatch | 1 | 2002 | 10 | 0.050 |
Why?
| | Static Electricity | 1 | 2022 | 113 | 0.050 |
Why?
| | Mice | 4 | 2013 | 18109 | 0.050 |
Why?
| | Pyrococcus | 1 | 2001 | 1 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2021 | 27 | 0.050 |
Why?
| | Methylation | 1 | 2022 | 230 | 0.050 |
Why?
| | DNA Primers | 2 | 2000 | 510 | 0.050 |
Why?
| | Fluorescence Polarization | 1 | 2001 | 26 | 0.050 |
Why?
| | Pyrococcus furiosus | 1 | 2001 | 3 | 0.040 |
Why?
| | Chromatography | 1 | 2001 | 24 | 0.040 |
Why?
| | Enzyme Stability | 2 | 1999 | 71 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2007 | 1158 | 0.040 |
Why?
| | Entropy | 1 | 2020 | 43 | 0.040 |
Why?
| | Genes, Archaeal | 1 | 2000 | 6 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2004 | 701 | 0.040 |
Why?
| | Candida albicans | 1 | 2000 | 57 | 0.040 |
Why?
| | Time Factors | 2 | 2001 | 6966 | 0.040 |
Why?
| | Dogs | 1 | 2021 | 427 | 0.040 |
Why?
| | DNA, Archaeal | 1 | 2000 | 17 | 0.040 |
Why?
| | Cations, Divalent | 1 | 1999 | 48 | 0.040 |
Why?
| | Phosphoglycerate Mutase | 1 | 1999 | 2 | 0.040 |
Why?
| | Open Reading Frames | 1 | 2000 | 132 | 0.040 |
Why?
| | PDZ Domains | 1 | 2019 | 5 | 0.040 |
Why?
| | Sequence Alignment | 1 | 2000 | 363 | 0.040 |
Why?
| | gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 11 | 0.040 |
Why?
| | Sorting Nexins | 1 | 2019 | 12 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2021 | 962 | 0.040 |
Why?
| | Saccharomyces cerevisiae | 2 | 2003 | 556 | 0.040 |
Why?
| | G-Quadruplexes | 1 | 2018 | 18 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2023 | 1243 | 0.040 |
Why?
| | Molecular Structure | 1 | 2019 | 503 | 0.040 |
Why?
| | Virus Internalization | 1 | 2018 | 65 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2021 | 634 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 333 | 0.030 |
Why?
| | Virulence | 1 | 2019 | 268 | 0.030 |
Why?
| | Ascorbate Peroxidases | 1 | 1997 | 2 | 0.030 |
Why?
| | Salicylic Acid | 1 | 1997 | 8 | 0.030 |
Why?
| | Transfection | 2 | 2012 | 943 | 0.030 |
Why?
| | Lipids | 1 | 2022 | 690 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1997 | 85 | 0.030 |
Why?
| | Tripartite Motif Proteins | 1 | 2017 | 41 | 0.030 |
Why?
| | Cricetulus | 1 | 2017 | 111 | 0.030 |
Why?
| | Point Mutation | 2 | 2009 | 237 | 0.030 |
Why?
| | CHO Cells | 1 | 2017 | 168 | 0.030 |
Why?
| | Gene Products, rex | 1 | 2017 | 1 | 0.030 |
Why?
| | Molecular Weight | 1 | 1997 | 329 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 815 | 0.030 |
Why?
| | Nucleoside-Triphosphatase | 1 | 2016 | 14 | 0.030 |
Why?
| | Chick Embryo | 1 | 2017 | 133 | 0.030 |
Why?
| | Simian foamy virus | 1 | 2016 | 3 | 0.030 |
Why?
| | Potyvirus | 1 | 2016 | 2 | 0.030 |
Why?
| | Plant Proteins | 1 | 1997 | 112 | 0.030 |
Why?
| | Hot Temperature | 1 | 2000 | 406 | 0.030 |
Why?
| | beta-Defensins | 1 | 2016 | 23 | 0.030 |
Why?
| | Chemical Precipitation | 1 | 2016 | 39 | 0.030 |
Why?
| | Cell Survival | 2 | 2011 | 1134 | 0.030 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2016 | 15 | 0.030 |
Why?
| | Acyltransferases | 1 | 2017 | 76 | 0.030 |
Why?
| | DNA Viruses | 1 | 2016 | 23 | 0.030 |
Why?
| | Protein Unfolding | 1 | 2016 | 31 | 0.030 |
Why?
| | Molecular Motor Proteins | 1 | 2016 | 46 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 2016 | 127 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 175 | 0.030 |
Why?
| | Protein Stability | 1 | 2016 | 175 | 0.030 |
Why?
| | Molecular Conformation | 1 | 2016 | 147 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2018 | 614 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2021 | 2525 | 0.030 |
Why?
| | DNA Helicases | 1 | 2016 | 142 | 0.030 |
Why?
| | Arginine | 2 | 2007 | 260 | 0.030 |
Why?
| | Signal Transduction | 2 | 2021 | 5169 | 0.030 |
Why?
| | Introns | 1 | 2015 | 254 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2021 | 1334 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2015 | 811 | 0.030 |
Why?
| | CpG Islands | 1 | 2014 | 165 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2014 | 183 | 0.030 |
Why?
| | Genetic Variation | 1 | 2018 | 1000 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2012 | 25 | 0.020 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein K | 1 | 2012 | 5 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 2012 | 86 | 0.020 |
Why?
| | Rats | 1 | 2021 | 5637 | 0.020 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2012 | 25 | 0.020 |
Why?
| | Mice, Knockout | 2 | 2012 | 3071 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2015 | 568 | 0.020 |
Why?
| | Apoptosis | 1 | 2021 | 2576 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3177 | 0.020 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2014 | 344 | 0.020 |
Why?
| | Genotype | 1 | 2016 | 1866 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 692 | 0.020 |
Why?
| | G2 Phase | 1 | 2011 | 39 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 825 | 0.020 |
Why?
| | Jurkat Cells | 1 | 2011 | 138 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-jun | 1 | 2010 | 57 | 0.020 |
Why?
| | Hydroxyl Radical | 1 | 2011 | 95 | 0.020 |
Why?
| | Cell Division | 1 | 2011 | 798 | 0.020 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2008 | 17 | 0.020 |
Why?
| | Nucleotides | 1 | 2009 | 127 | 0.020 |
Why?
| | Lamin Type A | 1 | 2007 | 47 | 0.020 |
Why?
| | Fibroblasts | 1 | 2012 | 1021 | 0.020 |
Why?
| | Tritium | 1 | 2006 | 72 | 0.020 |
Why?
| | Schiff Bases | 1 | 2006 | 7 | 0.020 |
Why?
| | 5-Hydroxytryptophan | 1 | 2006 | 21 | 0.020 |
Why?
| | DNA Topoisomerases, Type I | 1 | 2006 | 15 | 0.020 |
Why?
| | Solutions | 1 | 2006 | 168 | 0.020 |
Why?
| | Palmitic Acids | 1 | 2005 | 10 | 0.010 |
Why?
| | Chymotrypsin | 1 | 2005 | 23 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2005 | 78 | 0.010 |
Why?
| | Replication Protein A | 1 | 2005 | 14 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2005 | 236 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2005 | 324 | 0.010 |
Why?
| | Plasmids | 1 | 2005 | 365 | 0.010 |
Why?
| | Tryptophan | 1 | 2005 | 188 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 418 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2005 | 368 | 0.010 |
Why?
| | RNA, Fungal | 1 | 2003 | 73 | 0.010 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2003 | 91 | 0.010 |
Why?
| | Fluorometry | 1 | 2001 | 18 | 0.010 |
Why?
| | Carbocyanines | 1 | 2001 | 37 | 0.010 |
Why?
| | Fluorescein | 1 | 2001 | 24 | 0.010 |
Why?
| | Cell Membrane | 1 | 2005 | 724 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 48 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2001 | 87 | 0.010 |
Why?
| | Stem Cells | 1 | 2005 | 603 | 0.010 |
Why?
| | Enzyme Reactivators | 1 | 1999 | 2 | 0.010 |
Why?
| | Phanerochaete | 1 | 1999 | 3 | 0.010 |
Why?
| | Spectrophotometry | 1 | 1999 | 60 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2001 | 324 | 0.010 |
Why?
| | Vanadates | 1 | 1999 | 17 | 0.010 |
Why?
| | Escherichia coli Proteins | 1 | 2001 | 202 | 0.010 |
Why?
| | RNA Stability | 1 | 2000 | 116 | 0.010 |
Why?
| | Heme | 1 | 1999 | 76 | 0.010 |
Why?
| | Genes, Bacterial | 1 | 1999 | 166 | 0.010 |
Why?
| | Ligands | 1 | 2000 | 667 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1999 | 557 | 0.010 |
Why?
| | Mitochondrial Proteins | 1 | 2000 | 261 | 0.010 |
Why?
| | Temperature | 1 | 1999 | 669 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2001 | 912 | 0.010 |
Why?
| | Gene Expression | 1 | 1999 | 1492 | 0.010 |
Why?
|
|
Kvaratskhelia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|